Explore evidence

68.96 %HPV prevalence was 68.96% among fifty-eight WLWH enrolled in the study.

Gaboninfection à HPVpublished 2025Diseases (Basel, Switzerland)PubMeddocument of 12 observations

33.9 %Oral HPV prevalence was 33.9% among 61 unvaccinated men who have sex with men (MSM) taking preexposure prophylaxis (PrEP) in France.

Gaboninfection à HPVpublished 2019Open forum infectious diseasesPubMeddocument of 10 observations

The cumulative HPV viral loads of any HPV and high-risk HPV in ICC were significantly higher than those in CIN2/3 (p < 0.002 for any HPV; p = 0.02 for HR-HPV).

Gabonhigh-risk HPV · ICC · infection à HPV · lésions précancéreuses du col (CIN)published 2025Health science reportsPubMeddocument of 3 observations

11 genotypesHPV genotyping revealed the presence of 11 distinct HPV genotypes: 16, 18, 33, 31, 56, 6, 66, 70, 35, 45 and 81.

Gaboninfection à HPVpublished 2016Infectious agents and cancerPubMeddocument of 3 observations

92.4 %At least one HPV was detected in 92.4% of 132 Gabonese patients with high-grade neoplastic lesions.

Gaboninfection à HPVpublished 2023Infectious agents and cancerPubMeddocument of 6 observations

0.74 %The overall HPV prevalence in head and neck cancer biopsies was 0.74%.

Gabonhead and neck cancers · infection à HPVobserved 2009-2017published 2019Infectious agents and cancerPubMeddocument of 2 observations

60 %The rate of HPV integration in the host genome was 60% (3/5) for LSIL in an urban Gabonese population.

Gaboninfection à HPVpublished 2019Scientific reportsPubMeddocument of 7 observations

4.38 copies_per_10000_cellsThe cumulative viral loads of any HPV and HR-HPV possessed a good discriminatory ability to differentiate between CIN2/3 and ICC, with optimal cutoffs ranging from 4.38 to 4.85 copies per 10,000 cells.

GabonICC · infection à HPV · lésions précancéreuses du col (CIN)published 2025Health science reportsPubMeddocument of 3 observations

24.8 %The prevalence of HR-HPV genotypes was 24.8% among 399 women in Gabon.

Gaboninfection à HPVobserved 2024published 2024BMC women's healthPubMeddocument of 5 observations

0.977 correlation_coefficientHR-HPV viral load was significantly correlated with squamous cell inflammation (r = 0.977 and P = 0.001) among women in Gabon.

Gaboninfection à HPVobserved 2024published 2024BMC women's healthPubMeddocument of 5 observations

68 %Cervical HPV prevalence was 68.0% among first-generation immigrant African women attending the Centre Hospitalier Régional of Orléans, France.

Gaboninfection à HPVpublished 2021Journal of immigrant and minority healthPubMeddocument of 9 observations

71.4 %The rate of HPV integration in the host genome was 71.4% (5/7) for HSIL in an urban Gabonese population.

Gaboninfection à HPVpublished 2019Scientific reportsPubMeddocument of 7 observations

85.7 %The rate of HPV integration in the host genome was 85.7% (6/7) for carcinomas in an urban Gabonese population.

Gaboninfection à HPVpublished 2019Scientific reportsPubMeddocument of 7 observations

47 biopsiesHPV-positive results were detected in 47 biopsies, including 12 cases of CIN2/3 and 35 cases of ICC (4 adenocarcinoma and 31 squamous cell carcinoma).

Gabonadenocarcinoma · ICC · infection à HPV · lésions précancéreuses du col (CIN) · squamous cell carcinomapublished 2025Health science reportsPubMeddocument of 3 observations

71.4 %The integrated form of HPV16 genotype was found in 71.4% of samples regardless of cytological grade in an urban Gabonese population.

Gaboninfection à HPVpublished 2019Scientific reportsPubMeddocument of 7 observations

72.6 %Among 73 HPV-infected women, 72.6% (53/73) were infected with at least one high-risk HPV.

Gaboninfection à HPVobserved 2010published 2011Journal de gynecologie, obstetrique et biologie de la reproductioneurope_pmcdocument of 12 observations

68.6 %The majority of genital HPV-positive and genital HPV-negative women (68.6% and 68.7%, respectively) exhibited serum or cervicovaginal IgG to Gardasil-9® HR-HPV.

Gaboninfection à HPVpublished 2020PloS onePubMeddocument of 7 observations

7.7 %Highly oncogenic human papillomavirus (HPV) infections are responsible for 7.7% of cancers in developing countries, mainly cervical cancer.

Gaboncancer du col de l'utérus · infection à HPVpublished 2017Medecine et sante tropicalesPubMeddocument of 3 observations

54 %More than half (54.0%) of 50 anal swabs from men who have sex with men in Bamako, Mali were infected by at least one HPV genotype targeted by the Gardasil-9® vaccine.

Gaboninfection à HPVpublished 2021Infectious agents and cancerPubMeddocument of 10 observations

7.7 %Infections caused by high-risk human papillomavirus (HPV) are responsible for 7.7% of cancers in developing countries, mainly cervical cancer.

Gaboncancer du col de l'utérus · infection à HPVpublished 2017Expert review of anti-infective therapyPubMeddocument of 3 observations

44.57 %The Abbott RealTime High-Risk HPV test detected at least one HPV genotype in 44.57% of women regardless of the grade of cervical abnormalities.

Gaboninfection à HPVpublished 2017Virology journalPubMed

82.9 %The HPV detection rate was 82.9% among women with abnormal cytology.

Gaboninfection à HPVpublished 2016Infectious Agents and CancerOpenAlexdocument of 6 observationsDOI 10.1186/s13027-016-0098-1

31.2 %One-third (31.2%) of genital HPV-negative women did not show any serum and genital HPV-specific IgG.

Gaboninfection à HPVpublished 2020PloS onePubMeddocument of 7 observations

70 %The overall prevalence of anal HPV infection of any genotypes was 70.0% among 50 men who have sex with men in Bamako, Mali.

Gaboninfection à HPVpublished 2021Infectious agents and cancerPubMeddocument of 10 observations

24.3 %The prevalence of HPV infection among 300 women attending gynecological consultation in two health centers in Ouagadougou was 24.3% (73/300).

Gaboninfection à HPVobserved 2010published 2011Journal de gynecologie, obstetrique et biologie de la reproductioneurope_pmcdocument of 12 observations